Skip to search formSkip to main contentSkip to account menu

1 ML docetaxel 20 MG/ML Injection [Taxotere]

Known as: Docetaxel 20 mg in 1 mL INTRAVENOUS INJECTION, SOLUTION, CONCENTRATE [TAXOTERE], 1 ML Taxotere 20 MG/ML Injection, Taxotere 20 MG per 1 ML Injection 
National Institutes of Health

Related topics

Related topics

7 relations
DOCETAXEL ANHYDROUSEthanolInjectionPolysorbate 80

Broader (1)

docetaxel Injection [Taxotere]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Novel pH-triggered biocompatible polymeric micelles based on heparin–α-tocopherol conjugate for intracellular delivery of docetaxel in breast cancer
Abstract In this study, pH-triggered polymeric micelle comprising α-tocopherol (TOC) and heparin (HEP) was developed and loaded… 
Highly Cited
2014
Highly Cited
2014
Hyaluronan-Based Nanocarriers with CD44-Overexpressed Cancer Cell Targeting
The objective of the work was to evaluate the potential of hyaluronan-based nanoparticles as tumor-targeting nano-systems for… 
2000
2000
[Taxotere phase III trial on the first-line treatment of metastatic breast cancer]
OBJECTIVES: Doxorubicin and taxanes are the most effective agents in the treatment of advanced breast cancer. The aim of the… 
1997
1997
Docetaxel (Taxotere®) beim nichtkleinzelligen Bronchialkarzinom
Zusammenfassung□Hintergrund: Zahlreiche neue Medikamente stehen zur Zeit für Studien bei soliden Tumoren zur Verfügung. Zu ihnen… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)